YM BIOSCIENCES, Inc. (AM:YMI)

1.22

+0.03 (2.52%)

YM BIOSCIENCES, Inc. (AM:YMI) Delayed :
Previous Close	$1.19	52 Week High	$2.24
Open	$1.20	52 Week Low	$0.20
Day High	$1.27	P/E	N/A
Day Low	$1.20	EPS	$0.00
Volume	43,355
More YMI Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
YM	7	CYT	4
TGIC	2	HWCC	2
CHDX	2	DUK	2
ELON	2	FRE	2
TGIC	1	HWCC	1
CHDX	1	TIBX	1

View All Entities

Nov 5, 2009 07:51 AM Merriman Curhan Ford Initiates Coverage on YM BioSciences (YMI) with a Buy; Intriguing Opportunity
Sep 25, 2009 08:06 AM YM Biosciences (YMI) Misses Q2 View By A Penny
Sep 17, 2009 08:10 AM YM Biosciences (YMI) Reports Nimotuzumab Approved For Marketing In Mexico
Aug 10, 2009 01:13 PM Unusual 11 Mid-Day Movers 8/10: FRE, YMI, TFCO, ELON Higher; TGIC, HWCC, ASPS Lower
Aug 10, 2009 09:21 AM Morning Movers 8/10: FRE, YMI, FNM, OCN, TIBX, INO, ELON, CHDX, HWCC, TGIC

Nov 23, 2009 05:00PM YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
Nov 18, 2009 12:51PM YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
Nov 17, 2009 07:00AM YM BIOSCIENCES REPORTS CYT997 ORAL VASCULAR DISRUPTING AGENT RESULTS PRESENTED AT AACR-NCI-EORTC MEETING
Nov 11, 2009 05:00PM YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
Nov 2, 2009 02:08PM YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009

Nov 5, 2009 11:40 AM Analyst upgrades, downgrades and initiations: CMCSA, GAME, GRMN, ETN, FO, MDT, MSO ...
Sep 30, 2009 07:16 AM Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities
Sep 25, 2009 08:53 AM BioMed News Bytes: NicOx, Allos, Pressure BioSciences, YM BioSciences
Sep 18, 2009 04:40 AM BioMed News Bytes: Arena, ImmunoCellular, YM Bio
Sep 7, 2009 09:01 AM Small Cap Stocks Battling Brain Cancer

No comments are currently available.